- This event has passed.
Ocular Drug Delivery & Surgical Advances
November 9, 2022 @ 4:30 pm - 6:30 pm ESTFree
Drug-Device-Robotics Combination Technologies for the Eye
With an increased age-related high prevalence of eye diseases, ocular drug delivery technology innovation and robotic surgical advances present unprecedented opportunities and challenges.
Our three distinguished speakers will share with us some of the most exciting novel ophthalmic drug delivery technologies and robotic surgical innovation in the 21st century biology-based medicine from: 1) Subretinal gene & cell delivery precision to 2) Smart micro dose eye dropper, and 3) A minimally invasive localized suprachoroidal drug delivery route, all of which represent the new frontier of ophthalmic therapeutic innovation via improved delivery efficiency.
Together, these impressive advances are significantly advancing ophthalmic healthcare.
Sean Ianchulev, MD, MPH
Prof. of Ophthalmology,
Icahn School of Medicine, Mount Sinai and
Dir. of Technology and Innovations, NYEE;
Chairman & Founder, Eyenovia, Inc.
Topic: New Smart Micro dose Technology for Topical Ophthalmic Delivery-On Earth and in Space/Zero Gravity.
Dr. Ianchulev is a Harvard-trained physician executive, ophthalmic surgeon, inventor and serial entrepreneur, whose work has transformed the ophthalmic field. He is behind many breakthrough innovations: Lucentis (Genentech), ORA(Alcon), iStent (Iantrek Inc), MilOOP (Zeiss), Robotic surgery (NEEI) and Optejet (Eyenovia).
Richard B Rosen, MD
Retina Chief at New York
Eye & Ear Infirmary of the Mount Sinai
Dr. Rosen is Distinguished Professor of Ophthalmology, Vice Chair of Research, and Retina Chief at the New York Eye and Ear Infirmary of the Mount Sinai. He is a vitreoretinal surgeon, educator, and inventor with contributions in ocular imaging and surgical devices.
Cherry Wan, PhD
Senior Director at
Topic: The Superachoroidal Space and Superachoroidal Drug Delivery.
Dr. Wan is the senior director of engineering at Clearside Biomedical. She has held multiple engineering leadership positions in MedTech and pharmaceutical companies. Currently, Cherry is responsible for the SCS Microinjector, the proprietary microneedle to administer therapeutics into the suprachoroidal space.
Tina Guanting Qiu, MD, PhD, Consulting Chief Scientific Medical Officer, Ophthalmic Therapeutic Innovation
Moderator & Champion
Dr. Qiu is a biopharma physician with 20 years of experience in leading ophthalmic therapeutic frontiers of cell & gene therapy and ocular drug delivery. She has a proven track record of problem solving and creating product value (Lineage Cell, Inotek Pharma, Astellas, GSK).
Wed, Nov 9: 4:30pm – 6:30pm EST (Online Event)
- 4:30 – 5:00 General Networking
- 5:00 – 6:00 Panelist Forum
- 6:00 – 6:30 Meet the Speakers and more networking